Vincenzo Corbo, Associate Professor at University of Verona, posted the following on X:
“Thrilled to share our Nature Communications paper! We uncover a MAPKhigh myCAF (mapCAF) phenotype enriched in basal-like/squamous PDAC regions and extend evidence of this stromal signature to other tumors, linking it to immunotherapy resistance.”
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer
Authors: Lisa Veghini, Davide Pasini, Rui Fang, Pietro Delfino, Dea Filippini, Christian Neander, Caterina Vicentini, Elena Fiorini, Francesca Lupo, Sabrina L. D’Agosto, Carmine Carbone, Antonio Agostini, Geny Piro, Diego Rosa, Michele Bevere, Peter Markus, Diana Behrens, Claudio Luchini, Rita T. Lawlor, Aldo Scarpa, Giulia Biffi, Phyllis F. Cheung, Jens T. Siveke & Vincenzo Corbo
